Skip to main content

Pharmacy News and Views on Medication Safety and Scabies

Tracking # 20-1253682

$10.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

Join us for an informative session of Pharmacy News and Views, where we will explore the latest developments in pharmacy practice. In this episode, participants will gain insights into how the most recent updates on COVID-19 may influence pharmacy operations and patient care. We will delve into the clinical presentation, management, and prevention strategies for seasonal and trending diseases, equipping healthcare professionals with essential knowledge for effective patient management. Additionally, the discussion will cover new drugs, including their approved indications, common adverse effects, and potential drug interactions, ensuring that participants are well-informed about the latest therapeutic options. Lastly, we will highlight important drug alerts issued by the FDA, discussing their implications for patient care and safety. This comprehensive episode aims to provide valuable insights and practical knowledge for pharmacy professionals navigating today's healthcare landscape.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Pharmacist

1h General

Registered Pharmacy Technician

1h General

Michigan Board of Pharmacy

Pharmacist

1h General

Pharmacist Special Volunteer

1h General

Pharmacy Technician

1h General

Pharmacy Technician Special Volunteer

1h General

New Hampshire Board of Pharmacy

Certified Pharmacy Technician

1h Compounding CE

Pharmacist

1h Contact Hours

Disclosure statements

At the conclusion of this course, participants will be able to:

  1. Recognize how the latest updates on COVID-19 may impact pharmacy practice
  2. Describe the clinical presentation, management, and prevention of seasonal or trending diseases
  3. Review the approved indication, common adverse effects, and drug interactions for new drugs used to treat common disease states
  4. Identify important drug alerts by the FDA and implications for patient care


This activity was developed by AchieveCE free of any commercial support. Pete Kreckel, RPh, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.


Jaimini Patel, RPh, MBA, planner for this educational event, also has no relevant financial relationship(s) with ineligible companies to disclose.


Take it Here

  • This course reports to CE broker immediately upon completion.
  • Complete all courses at your own pace online.
  • Quality and enjoyable courses.
  • Modern experience, accessible from any device. 
  • All courses affordably priced.